These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

581 related items for PubMed ID: 26037791

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment with tiludronate has a similar effect to risedronate on Paget's disease activity assessed by bone markers and bone scintigraphy.
    Peris P, Alvarez L, Vidal S, Martínez MA, Monegal A, Guañabens N.
    Clin Exp Rheumatol; 2007; 25(2):206-10. PubMed ID: 17543143
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative responses of bone turnover markers to bisphosphonate therapy in Paget's disease of bone.
    Reid IR, Davidson JS, Wattie D, Wu F, Lucas J, Gamble GD, Rutland MD, Cundy T.
    Bone; 2004 Jul; 35(1):224-30. PubMed ID: 15207761
    [Abstract] [Full Text] [Related]

  • 6. Biochemical assessment of Paget's disease of bone.
    Shankar S, Hosking DJ.
    J Bone Miner Res; 2006 Dec; 21 Suppl 2():P22-7. PubMed ID: 17229003
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates.
    Alvarez L, Peris P, Guañabens N, Vidal S, Ros I, Pons F, Filella X, Monegal A, Muñoz-Gomez J, Ballesta AM.
    Arthritis Rheum; 2003 Mar; 48(3):824-8. PubMed ID: 12632438
    [Abstract] [Full Text] [Related]

  • 9. Clinical efficacy of oral risedronate therapy in Japanese patients with Paget's disease of bone.
    Ohara M, Imanishi Y, Nagata Y, Ishii A, Kobayashi I, Mori K, Ito M, Miki T, Nishizawa Y, Inaba M.
    J Bone Miner Metab; 2015 Sep; 33(5):584-90. PubMed ID: 25319558
    [Abstract] [Full Text] [Related]

  • 10. Long-Term Bone Scintigraphy Results After Intravenous Zoledronate in Paget's Disease of Bone.
    Reid IR, Maslowski K.
    Calcif Tissue Int; 2017 Jul; 101(1):43-49. PubMed ID: 28324123
    [Abstract] [Full Text] [Related]

  • 11. Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity.
    Pons F, Alvarez L, Peris P, Guañabens N, Vidal-Sicart S, Monegal A, Pavía J, Ballesta AM, Muños-Gómez J, Herranz R.
    Nucl Med Commun; 1999 Jun; 20(6):525-8. PubMed ID: 10451864
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Two cases of monostotic Paget's disease: effects of bisphosphonate.
    Hoshiro M, Harada T, Iwai H, Miyatake T, Nishimura A, Ohno Y, Aoki N.
    Endocr J; 2003 Aug; 50(4):385-92. PubMed ID: 14599111
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    Phillips J, Subedi D, Lewis SC, Keerie C, Ralston SH.
    ; 2024 06. PubMed ID: 38950131
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.
    Alvarez L, Peris P, Guañabens N, Vidal S, Quintó L, Monegal A, Pons F, Ballesta AM, Muñoz-Gómez J.
    Rheumatology (Oxford); 2004 Jul; 43(7):869-74. PubMed ID: 15054158
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of methods of assessing response of Paget's disease to bisphosphonate therapy.
    Patel S, Coupland CA, Stone MD, Hosking DJ.
    Bone; 1995 Feb; 16(2):193-7. PubMed ID: 7756047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.